Related by context. All words. (Click for frequent words.) 66 oral prodrug 65 selective androgen receptor modulator 65 metaglidasen 65 generation purine nucleoside 64 Panzem R NCD 64 virus HCV protease inhibitor 64 TELINTRA R 64 PDE4 inhibitor 64 Annamycin 64 HGS ETR1 63 PNP inhibitor 63 volociximab 63 Aflibercept 63 cetuximab Erbitux R 63 PEGylated Fab fragment 63 XmAb ® 63 CYT# potent vascular disrupting 63 alvespimycin 63 TBC# 63 Factor VIIa 63 oral nucleoside analogue 63 humanized antibody 62 OMP #R# 62 PRT# 62 GRNVAC1 62 IMA# 62 RhuDex ® 62 investigational monoclonal antibody 62 CCR9 antagonist 62 Pimavanserin 62 IAP inhibitor 62 TELINTRA 62 HuMax CD4 62 protein tyrosine phosphatase 1B 62 IMC #B 62 Oral NKTR 62 epothilone 62 GVAX ® 62 Sudhir Agrawal D.Phil 62 VEGFR2 inhibitor 62 refractory chronic lymphocytic 62 Nanobody 62 IMiDs ® 62 dasatinib Sprycel ® 61 AEG# 61 non nucleoside inhibitor 61 TKM ApoB 61 Sym# 61 otelixizumab 61 CDK cyclin dependent 61 antibody MAb 61 XL# XL# 61 DepoVax ™ 61 NXL# 61 mGluR5 NAM 61 immunotoxin 61 lintuzumab SGN 61 Spiegelmer ® 61 BiTE R 61 PEG SN# 61 CD# antibody [001] 61 Proxinium TM 61 Lixivaptan 61 forodesine hydrochloride 61 anionic backbone 61 Pradefovir 61 human IgG1 monoclonal 61 pradefovir 61 small molecule glucokinase 61 Zenvia ™ 61 BEMA TM Fentanyl 61 dacetuzumab 61 TRIOLEX HE# APOPTONE HE# 61 AAG geldanamycin analog 61 Tumour Vascular Disrupting Agent 61 MGd 61 vapreotide acetate 61 receptor inhibiting monoclonal 61 phase IIb clinical 61 HuLuc# 61 ASONEP ™ 61 anti CD3 monoclonal 61 Capesaris 61 forodesine 61 XmAb# 61 ABILIFY ® 61 R#/MEM # 61 Archexin 60 NU# direct 60 EOquin 60 systemic RNAi therapeutic 60 drug conjugate 60 cortisol synthesis 60 elotuzumab 60 Solazed 60 mertansine 60 Epothilone D 60 Plicera 60 inhaled liposomal ciprofloxacin 60 HCD# [002] 60 aldehyde dehydrogenase ALDH2 deficiency 60 XL# anticancer compounds 60 PF # [002] 60 hormone LHRH antagonist 60 IMPDH inhibitor 60 ALN PCS 60 interferon gamma 1b 60 intranasal formulation 60 CYP#A# CYP#D# 60 LymphoStat B TM 60 orally administered inhibitor 60 pediatric acute lymphoblastic 60 PEGylated interferon 60 MKC# MT 60 liposomal formulation 60 Troxatyl 60 polymerase inhibitor 60 Phase Ib study 60 targeted radiotherapeutic 60 HCV RNA polymerase 60 Vitaxin 60 XOMA 3AB 60 HGS# 60 Syncria 60 Apoptone 60 davalintide 60 topical gel formulation 60 IMiDs R 60 Relivar 60 pafuramidine maleate 60 goserelin 60 dextromethorphan quinidine 60 ELACYT 60 polysaccharide polymer 60 Elotuzumab 60 XL# XL# XL# XL# 60 delivers fluocinolone acetonide FA 60 TLR7 agonist 60 ostarine 59 Trofex 59 AQ4N 59 dimebon latrepirdine 59 SinuNase ™ 59 agonistic human 59 nalbuphine ER 59 kidney urologic 59 ospemifene 59 CD# CEA 59 THR beta agonist 59 nucleoside analog 59 M2 subunit 59 Apoptone HE# 59 relapsed leukemia 59 oral talactoferrin 59 CORT # 59 nitric oxide donating prostaglandin 59 oral dihydropyrimidine dehydrogenase DPD 59 lumiliximab 59 huC# DM4 59 CRTH2 59 Pruvel TM 59 accumulate preferentially 59 HGS ETR2 59 castrate resistant prostate cancer 59 including eniluracil ADH 59 OMP #M# 59 orally bioavailable 59 motexafin gadolinium Injection 59 XmAb 59 HGS ETR1 mapatumumab 59 CB2 selective receptor agonist 59 sapacitabine CYC# 59 tolevamer 59 Azedra TM 59 delta opioid receptor 59 cutaneous T 59 AKT inhibitor 59 Theratope 59 Chemophase 59 GRN# 59 INS# [001] 59 Synavive 59 Angiocept 59 NS5b 59 CCX# 59 JAK1 59 Alocrest 59 peptidic compound 59 multi kinase inhibitor 59 rxRNA 59 Aganocide 59 Evoltra ® 59 cathepsin K inhibitor 59 class mGluR5 inhibitor 59 mapatumumab 59 Guanilib 59 recurrent glioblastoma multiforme 59 HuMax TAC 59 Ostarine ™ 59 Shigamabs ® 59 mda 7 59 ChronVac C R 59 ASG 5ME 59 evaluating tivozanib 59 telomerase therapeutic 59 5 lipoxygenase activating 59 MAGE A3 ASCI 59 Cannabinor 59 GLP toxicology studies 59 Maxy G# 59 Zenvia TM 59 systemically administered 59 Androxal TM 59 EZN 59 fusion inhibitor 59 daclizumab 59 pralatrexate injection folate analogue 59 JAK inhibitor 59 Xcytrin R 59 PLK1 SNALP 59 PANVAC VF 59 PDE# 59 acetonide FA 59 Solazed ™ 59 Luteinizing Hormone Releasing Hormone 59 IMC A# 59 Litx 59 Insegia 59 anti PlGF 59 LHRH receptor positive 58 YONDELIS 58 Budesonide foam crofelemer 58 HuMax CD# 58 ularitide 58 Rigel R# 58 generation HCV nucleotide 58 Mipomersen 58 VitiGam 58 5 fluorouracil leucovorin 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 PSMA ADC 58 TOCOSOL Paclitaxel 58 GVAX R 58 development peramivir neuraminidase 58 methylnaltrexone 58 evaluating picoplatin 58 IAP inhibitors 58 selective inverse agonist 58 Zemiva TM 58 ATL# [002] 58 eniluracil 58 CTA# Injection 58 administered subcutaneously 58 Romidepsin 58 vinca alkaloid 58 XP# XP# 58 Quinamed 58 Panzem NCD 58 ENMD # 58 evaluating T DM1 58 IMiDs ® compound 58 SAR# [004] 58 Tyrima 58 Nasulin ™ 58 cilengitide 58 ALN TTR# 58 UVIDEM 58 FOLOTYN ® 58 novel therapeutic antibodies 58 oncolytic virus therapies 58 Begins Dosing 58 basal insulin analogue 58 humanized monoclonal antibody 58 Panzem R 58 TLR9 agonist 58 Alzhemed TM 58 tosedostat 58 Protexia R 58 Pancreate 58 cancer immunotherapies 58 recombinant PSMA vaccine 58 ApoB SNALP 58 Phase 1a clinical 58 ImmunoVEX HSV2 58 PNT# 58 PSN# [002] 58 Canvaxin TM 58 Vicriviroc 58 IIa trial 58 HQK 58 immunomodulatory therapy 58 DermaVir Patch 58 TRACON Pharmaceuticals 58 Personalized Immunotherapy 58 cleavable linker 58 TKB# 58 INSPIRE Trial Phase III 58 Preclinical studies suggest 58 ESBA# 58 GED aPC 58 ocular formulation 58 EndoTAG TM -1 58 Phase IIb clinical trials 58 Intermezzo ® zolpidem tartrate 58 targeting CD# 58 nilotinib Tasigna ® 58 Phase 2a trial 58 Pruvel ™ 58 OXi# 58 selective GR 58 Aurora Kinase 58 signal transduction inhibitor 58 ATRA IV 58 hypoxia activated prodrug 58 Amigal 58 hepatitis C HCV 58 alpha folate receptor 58 MCSP respectively 58 cell lymphoma CTCL 58 TRIOLEX HE# 58 Intravenous CP 58 AzaSite Plus 58 Empatic ™ 58 Zybrestat 58 thrombin component 58 CRLX# 58 modified glutathione analog 58 Investigational Oral 58 Nanobody R 58 compound AEZS 58 JAK2 inhibitor 58 proprietary BiTE ® 58 TG# [003] 58 sodium glucose cotransporter 58 leading oral taxane 57 MEK inhibitor 57 radiation sensitizer 57 ceftazidime 57 Naglazyme R 57 Iluvien ® 57 markets Testim ® 57 TransVax tm 57 busulfan 57 CTAP# Capsules 57 CEQ# 57 ZK EPO 57 TOCOSOL Camptothecin 57 CD4 monoclonal antibody 57 generation antisense 57 Onalta 57 siRNA therapeutic 57 PD LID 57 LHRH antagonist 57 AtuRNAi 57 oral proteasome inhibitor 57 seliciclib CYC# 57 histone deacetylase HDAC inhibitor 57 investigational compounds 57 Aurora kinase 57 MSCRAMM ® 57 HuMax EGFr 57 orally administered synthetic retinoid 57 pan histone deacetylase 57 Phase Ib clinical trials 57 Crofelemer budesonide foam 57 midstage clinical 57 beta 1a 57 ESTRASORB 57 MT#/MEDI-# 57 OHR/AVR# 57 Sapacitabine 57 NTDDS 57 MKC# 57 Camptosar ® irinotecan 57 Onalta ™ 57 Novolimus 57 hyperphenylalaninemia HPA due 57 Stimuvax R 57 SNT MC# 57 KNS # 57 PEGylated 57 unpartnered 57 docetaxel Taxotere R 57 potent antiproliferative 57 EGS# 57 ALN TTR 57 Cx# [002] 57 tezampanel NGX# 57 oral ghrelin agonist 57 RAS MAPK pathway 57 oral picoplatin 57 Fc fusion protein 57 CCR5 mAb 57 personalized dendritic cell 57 chimeric monoclonal antibody 57 EDEMA3 57 Bezielle 57 ONCONASE R 57 refractory gout 57 HSP# inhibitor 57 Tesetaxel 57 cannabinor 57 PEG irinotecan 57 TACI Ig 57 PEGPH# 57 orally dosed 57 pharmacokinetic PK study 57 Zolinza 57 candidate REP# 57 novel histone deacetylase 57 BiTE antibody 57 Provectus Pharmaceuticals specializes 57 novel synthetic peptide 57 phase IIb study 57 Kosan dependence 57 romazarit 57 Bicifadine 57 Prodarsan R 57 Exelixis compounds 57 KSP inhibitor 57 Endotis 57 NOX E# 57 OvaRex ® MAb 57 Aplidin 57 gemcitabine cisplatin 57 Solazed TM 57 intravesical infusion therapy 57 torezolid phosphate 57 ALTROPANE R 57 Trofex TM 57 Metastatic Melanoma 57 developing ostarine selective 57 bicifadine 57 Inc. www.micromet inc.com 57 Phase 2b Clinical Trial 57 highly selective endothelin 57 Zalypsis 57 CDP# 57 FOLFOX6 chemotherapy regimen 57 CFTR inhibitors 57 peripherally acting 57 gastrin analogue TT 57 stage antibody MT# 57 targets Galectin receptors 57 maximally tolerated dose 57 telaprevir VX 57 RenaZorb 57 PI3K inhibitor 57 Proellex TM 57 2 methoxyestradiol 57 Aeolus Pharmaceuticals Announces 57 SAR# [002] 57 Initiate Phase 57 JAK inhibitors 57 allosteric modulator NAM 57 TKM PLK1 57 HCV nucleoside 57 Protexia ® 57 novel L DOS# 57 next generation URAT1 57 Uvidem 57 GW# [003] 57 ASONEP TM 57 PGL# 57 plasma kallikrein inhibitor 57 romidepsin novel 57 pan HDAC inhibitor 57 recombinant subunit vaccine 57 Sphingomab 57 HyperAcute 56 AVE# 56 celgosivir 56 antisense drug 56 therapeutic monoclonal antibody 56 RNA antagonists 56 apoptosis proteins 56 maturation inhibitor 56 Cathepsin S 56 ALS #-# 56 receptor tyrosine kinase inhibitor 56 PEGylated irinotecan 56 generation PNP inhibitor 56 HepeX B 56 GSK # 56 CINOD 56 sodium glucose transporter 56 class anticancer quinolone 56 Phase 2a clinical trials 56 PI3K/Akt pathway inhibitor 56 Marqibo TM 56 obatoclax 56 metastatic renal cell 56 CMV vaccine 56 tubulin inhibitor 56 nucleoside 56 UltiMAb 56 AGS PSCA 56 CYT# vascular disrupting 56 Micromet BiTE 56 OncoVEX GM CSF 56 Ophena TM 56 OvaRex 56 MT# MEDI 56 Survivin antagonist 56 investigational HCV polymerase 56 5 FU leucovorin 56 ARG# 56 HCV NS3 protease 56 danoprevir 56 urocortin 2 56 Alfacell proprietary ribonuclease 56 SPL# Gel vaginal microbicide 56 Davanat 56 MET inhibitor 56 clinical trials Archexin 56 PDX pralatrexate 56 atacicept 56 immune modulating 56 trastuzumab Herceptin R 56 E2F Decoy 56 drug conjugate ADC 56 rindopepimut 56 ARIKACE ™ 56 compound perifosine 56 R roscovitine 56 Targeted Chemotherapy 56 nucleotide analog polymerase inhibitor 56 phase IIb trial 56 Aurexis 56 dyskinesia PD LID 56 Amigal TM 56 docetaxel Taxotere ® 56 Traficet EN 56 dermatology biopharmaceutical company 56 prostone 56 TRO# 56 epothilones 56 EVIZON ™ 56 Homspera TM 56 PORxin TM 56 DU #b 56 proteasome inhibitor 56 tiapamil 56 Aurora kinase inhibitor 56 molecular imaging radiopharmaceutical 56 Squalamine 56 Hematide TM 56 initiated Phase Ib 56 Fx #A 56 ErbB3 HER3 56 Anavex #-# 56 MKC# MKC# PP 56 DXL# 56 MTP inhibitor 56 Allovectin 7 56 generation FBPase inhibitor 56 Synavive ™ 56 selectively inhibits 56 Copegus ribavirin 56 inhibit replication 56 isoform selective 56 personalized cellular immunotherapy 56 Phase IIb trials 56 drug pipeline TAFA# 56 S#P# 56 topical antifungal product 56 Elvitegravir 56 pharmacological chaperone 56 TRAIL receptor antibodies 56 Aganocide ® 56 memantine HCl 56 evaluating satraplatin 56 MAXY G# 56 CCR5 antagonist 56 antimitotic 56 aminocandin 56 Ozarelix 56 imatinib Gleevec ® 56 toenail onychomycosis 56 dacetuzumab SGN 56 CR# vcMMAE 56 Phase #b/#a clinical 56 administered intranasally 56 taxane chemotherapy 56 Cloretazine 56 Hsp# inhibitor 56 novel chimeric natriuretic 56 CB2 receptor selective 56 5 HT6 56 VQD 56 GRN#L 56 anti botulism antibody 56 selective kinase inhibitor 56 SIRT1 activators 56 Nanobody ® 56 albiglutide 56 BiTE 56 Altastaph 56 DCCR 56 Akt inhibitor 56 ARRY # 56 synthetic retinoid 56 PHX# 56 RNAi therapeutic targeting PCSK9 56 FOLFOX chemotherapy 56 non nucleoside HCV 56 AQD class 56 lead molecular radiotherapeutic 56 candidate CRLX# 56 TRIOLEX ™ 56 antisense inhibitors 56 Genasense ® oblimersen 56 telomerase inhibitor drug 56 Desmoteplase 56 vascular disrupting agent 56 Nventa proprietary CoVal 56 Hematide ™ 56 GV# [001] 56 DNA methyltransferase inhibitors 56 CCR2 antagonists 56 integrin inhibitor 56 faropenem 56 peptidomimetic 56 pomalidomide 56 diabetes irritable bowel 56 NeuVax 56 generation Hsp# inhibitor 56 oral Hsp# inhibitor 56 PDE# inhibitors 55 siRNAs targeting 55 selective S#P# receptor agonist 55 rNAPc2 55 erlotinib Tarceva ® 55 compound INCB# 55 Cetrorelix 55 selective immunoproteasome inhibitor 55 EndoTAG 55 NovaBay Aganocide 55 pipeline GlycoPEG GCSF 55 essential thrombocythemia ET 55 initiated Phase 1b 55 investigational protease inhibitor 55 HCV NS5B polymerase 55 TMC# [002] 55 dihydrochloride Tablets 55 mitogen activated ERK kinase 55 Inhalation Solution 55 intranasal insulin product 55 pharmacogenomic translational research 55 Phase 1b clinical trials 55 desvenlafaxine succinate 55 INCB# [001] 55 Nasdaq PGNX today 55 Telik logo TELINTRA 55 ALN HPN 55 lead Aganocide compound 55 Aztreonam lysine 55 triphendiol 55 entinostat 55 solanezumab 55 Cardio Vascu Grow 55 Nanobodies ® 55 Kahalalide F 55 Tezampanel 55 registrational trial 55 inflammatory autoimmune diseases 55 bardoxolone 55 HCV protease inhibitors 55 lipid nanoparticle 55 virus AAV 55 candidate XP# 55 demonstrated antitumor activity 55 GSK '# 55 Diamyd ® 55 subcutaneous immunoglobulin 55 protein kinase inhibitor 55 IND submission 55 mGluR2 NAM 55 orally inhaled migraine 55 PI3K/mTOR 55 selectin antagonist 55 nanoviricide drug 55 metastatic castration resistant 55 EP #R 55 beta interferons 55 MVA BN R 55 multicenter Phase 55 lexidronam injection 55 developing Zerenex TM 55 Phase #/#a trial 55 transcriptase inhibitor NNRTI 55 Radezolid 55 personalized immunotherapy 55 Epothilones 55 maturation inhibition 55 rALLy clinical trial 55 lixivaptan 55 deforolimus 55 Veronate 55 ulimorelin 55 Daclizumab 55 motesanib 55 gallium containing 55 radezolid 55 HCV protease inhibitor 55 HCV polymerase inhibitors 55 Through Glycoscience R 55 midstage trials 55 HER2 positive metastatic breast 55 REGN# 55 LE DT 55 triciribine phosphate monohydrate 55 novel topoisomerase 55 semi synthetic lipoglycopeptide 55 OvaRex R 55 bevacizumab Avastin R 55 Curaxin 55 panitumumab Vectibix 55 regorafenib 55 Xanafide 55 therapeutic monoclonal antibodies 55 potently inhibit 55 RELOVAIR ™ 55 sulfonylhydrazine class 55 anticancer compound 55 targeting PCSK9 55 Prodarsan ® 55 Aplidin R 55 apoptosis inducer 55 developing ACAPODENE 55 prokinetic agent 55 transthyretin TTR 55 gefitinib Iressa 55 PORxin TM platforms 55 enzastaurin 55 JAK3 inhibitor 55 phase IIa clinical 55 4SC AG ISIN DE# 55 Curaxin CBLC# 55 NASDAQ INGN 55 Cloretazine ® 55 multitargeted 55 PCK# 55 Phase #/#a 55 hypoxia selective 55 AN# novel 55 novel RNAi therapeutics 55 Nicotine Conjugate Vaccine 55 SNALP technology 55 CTA# 55 2NTX 55 molecular imaging radiopharmaceuticals 55 pentadentate logo R 55 MAXY VII 55 Tarvacin TM 55 trastuzumab DM1 T DM1 55 torezolid 55 apricitabine ATC 55 Ridaforolimus 55 P#X# 55 Hedgehog pathway inhibitor 55 Ostabolin C TM 55 novel orally bioavailable 55 gastro intestinal inflammation 55 Delafloxacin 55 nucleotide analog 55 Hsp# Inhibitor 55 investigational oral hepatitis C 55 Nasulin 55 huN# DM1 55 please visit http:/www.vandapharma.com 55 Aganocide R 55 DOS# 55 Affilin ® 55 BIM #A# 55 histone deacetylase HDAC inhibitors 55 mg TID 55 HuMax 55 MDS AML 55 QLT# 55 MEK Inhibitor 55 clinical trials dacetuzumab SGN 55 adecatumumab MT# 55 Zalbin 55 HCV polymerase 55 Elagolix 55 MAXY alpha 55 immunotherapeutic approaches 55 preclinically 55 JAK3 55 Phase Ib clinical 55 ANAVEX #-# [002] 55 TOCOSOL 55 phase Ib 55 androgen receptor antagonist 55 OXIGON TM 55 EVIZON TM squalamine lactate 55 Cytogen marketed 55 compound KOS 55 Symadex 55 fesoterodine 55 IGN# 54 inhibit metastasis 54 IMiD 54 Phase IIa trials 54 OncoVEX 54 compound PMX # 54 Sulonex 54 clinical trials lintuzumab SGN 54 inhibit oxidative stress 54 investigational humanized monoclonal antibody 54 Relovair 54 ART# 54 GAP #B# 54 mg q#h 54 integrase inhibitor 54 Parkinson disease levodopa induced 54 Myocet 54 Onconase 54 hematological indications 54 ridaforolimus 54 CORT # estimates 54 Behcet uveitis 54 vaccine GRNVAC1 54 using VIAdel TM 54 DPX Survivac 54 Nektar proprietary 54 MediGene focuses 54 Micromet proprietary BiTE 54 VersaFilm 54 BCX# 54 humanised antibody 54 Blinatumomab 54 small molecule tyrosine 54 HIV integrase inhibitors 54 cMET 54 GALNS 54 Presents Preclinical Data 54 HCV protease 54 Initiates Phase II 54 farletuzumab 54 inhaled formulation 54 pegylated interferons 54 3 registrational trial 54 sodium Injection 54 hyaluronidase enzyme 54 phase III isavuconazole 54 JAK2 Inhibitor 54 investigational hepatitis C 54 HEPLISAV ™ 54 cabozantinib 54 Asentar TM 54 therapeutic peptide 54 Kinase Inhibitor 54 Ovitrelle R Serostim 54 Mesafem 54 RLY# 54 Reports Preclinical Data 54 commercialize CorMedix drug 54 product candidate Lpathomab 54 poly ADP ribose polymerase 54 Spiegelmer 54 Amplimexon 54 p# inhibitor 54 Albugon 54 nucleoside analogues 54 belinostat 54 Zemiva ™ 54 MEK inhibitors 54 PEG Interferon lambda 54 HCV nucleotide polymerase inhibitor 54 teduglutide 54 taxane resistant 54 RNAi therapeutic targeting 54 CXB# 54 adipiplon 54 crofelemer 54 cancer indications bafetinib 54 GPR# agonist 54 CRD5 54 CORLUX CORT # 54 hematological tumors 54 lucinactant 54 platinum chemotherapeutic 54 SB# ONX 54 Presents Preclinical 54 Phase Ib 54 hepatitis C protease inhibitor 54 IL# PE#QQR 54 Omacetaxine 54 PSN# [001] 54 Nanobodies 54 Enhanze Technology 54 Antibody Drug Conjugate 54 HuCAL antibodies 54 BCR ABL inhibitors 54 Panzem 54 anaplastic lymphoma kinase ALK 54 ongoing Phase 1b 54 muscarinic receptor agonist 54 Alexza Staccato 54 inhaled AAT 54 Prednisporin 54 irreversible inhibitor 54 OMNARIS HFA 54 budesonide MMX ® 54 MAb 54 delivered RNAi therapeutic 54 Tarvacin Anti Cancer 54 recombinant factor VIIa 54 HspE7 54 IND enabling 54 radiotherapeutic 54 Telatinib 54 Lisofylline LSF 54 PREOS R 54 RenaZorb TM 54 Homspera ® 54 GLPG# 54 platforms GVAX 54 Azedra 54 ZFP Therapeutic 54 VISICOL R 54 Asentar 54 Onco TCS 54 Tarmogen 54 indibulin 54 Phase 2b Trial 54 ALN VSP 54 gamma secretase inhibitor 54 RGB # 54 epigenetic therapies 54 mGluR5 negative 54 lipid particle 54 atrasentan 54 NF kB Decoy 54 drug NP2 Enkephalin 54 additional purine nucleotide 54 Phase III Pivotal 54 Tyzeka Sebivo 54 PXD# 54 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 54 Oracea TM 54 elagolix 54 P#X# antagonist 54 active AKT inhibitor 54 refractory CLL 54 Locked Nucleic Acid 54 carcinoid syndrome diabetes 54 Alnylam #x# 54 SMT C# 54 vosaroxin 54 fosbretabulin 53 radiolabeled monoclonal antibody 53 R MSCRAMM 53 TRANSDUR ® 53 nitric oxide donating 53 LEX System 53 Viramidine 53 thiazolides 53 anticancer therapeutics 53 IPL# 53 adrenergic regulation 53 acid phosphatase PAP 53 flu mAb 53 Lu AA# 53 PS# [001] 53 neuronal nicotinic receptor NNR 53 Thiovir 53 Potelligent Technology 53 Dapagliflozin 53 HepeX B TM 53 APOPTONE 53 tumors GIST 53 SuperAntibody 53 HIV integrase inhibitor 53 Vilazodone 53 Oxytrex TM 53 HuCNS SC ® 53 CCR2 53 developing Zerenex ferric 53 highly selective adenosine 53 include VALSTAR TM 53 markets COLAZAL 53 anti amnesic 53 Selzentry maraviroc 53 Inhibiting Nitric Oxide Donating 53 phase IIa 53 immunological diseases 53 L BLP# 53 world safest multivalent 53 Nasdaq ENMD 53 ganetespib 53 Arno Therapeutics 53 Submits NDA 53 estrogen receptor beta agonist 53 HuCAL antibody 53 selective estrogen receptor modulator 53 immunotherapeutic vaccine